Triple‐negative breast cancer (TNBC), an aggressive tumor that lacks estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2),1 is the most common subtype causing mortality in breast cancer accounting for approximately 15%–20% of all breast cancers. This evidence concerns the gene ESR1 and breast carcinoma.